Abstract
The myth behind the aetiology and efforts towards treatment and prevention of breast cancer were always present since antiquity. Two Egyptian papyruses, written approximately 1600 B.C. are concerned with the disease, the Edwin Smith Papyrus and the Ebers Papyrus. The first includes a case (no. 45) of “bulging tumour of the breast recorded in lines 9 to 20 of the reproduction:
“If thou examinest a man having bulging tumours on his breast, (and) thou findest that (swellings) have spread over the breast; if thou puttest thy hand upon his breast upon these tumours, (and) thou findest them very cool, there being no fever at all therein when thy hand touches him, they have no granulation, they form no fluid, and they are bulging to thy hand, thou should say concerning him one having bulging tumours. An ailment with which I will attend. There is no (treatment)”.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. International Journal of Cancer. 2001;94:153–6.
Ferlay J, Pisani P, Parkin DM, editors: Globocan 2000: IARC Press; 2001.
Sankaranarayanan R, Black RJ, Parkin DM: An overview of cancer survival in developing countries. In Sankaranarayanan R, Black RJ, Swaminathan R, Parkin DM, editors. Cancer survival in developing countries. Lyon: IARC Press, 1998, p. 135–75.
Parkin DM, Whelan SL, Ferlay J, Raymond L, Young JL, editors: Cancer Incidence in Five Continents. Lyon: IARC Press; 1997.
Stewart WB, Kleihues P, editors: World Cancer Report. Lyon: IARC Press; 2003.
Ibrahim AS, Hussein H, Ismail K, Hablas A, Abdel BI, Ramadan M, editors: Cancer profile in Gharbiah-Egypt; Methodology and results; 1999.
Hoffman M, de Pinho H, Cooper D, Sayed R, Dent DM, Gudgeon A, et al: Breast cancer incidence and determinants of cancer stage in the Western Cape. South African Medical Journal. 2000;90:1212–6.
Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA: Solid breast nodules: use of sonography to distinguish between benign and malignant lesions.[comment]. Radiology. 1995;196:123–34.
El Gemeie E, El Didi M, Nouh A: A fine needle aspiration of breast lesions: the experience of the Egyptian National Cancer Inst. J. Egyptian National Cancer Institute 1997;9:239–46.
Salih AM, El Morsy B, Mohammed NH: Cytopathological diagnosis of breast lesions among Egyptian by fine needle sampling without aspiration: using only the needle. J. Egyptian National Cancer Institute 1996;8:203–11.
Dipo-Ba S, Badian M, Niang EH, Ly Ba A, Alfidja A, Favre Y: Contribution of mammography and echography to the diagnosis of breast cancer in Dakar: apropos of 25 cases. Dakar Medical. Dakar Medical 1997;42:114–17.
El Badawi M, Zaki I, Tantawi S: Magnetic response mammography diagnostic potentials in breast cancer. J. Egyptian National Cancer Institute 1999;11:91–98.
Saber RA: Assessment of carcinoma by 99mTC-Sestamibi scintimammography: Effect of lesion site, size, and histopathological characteristics. J. Egyptian National Cancer Institute 2000;12:183–89.
Mbonde MP, Amir H, Mbembati NA, Holland R, Schwartz-Albiez R, Kitinya JN: Characterisation of benign lesions and carcinomas of the female breast in a sub-Saharan African population. Pathology, Research & Practice. 1998;194:623–9.
Mbonde MP, Amir H, Schwartz-Albiez R, Akslen LA, Kitinya JN: Expression of estrogen and progesterone receptors in carcinomas of the female breast in Tanzania. Oncology Reports. 2000;7:277–83.
Gebremedhin A, Shamebo M: Clinical profile of Ethiopian patients with breast cancer. East African Medical Journal. 1998;75:640–3.
Anyanwu SN: Breast cancer in eastern Nigeria: a ten year review. West African Journal of Medicine. 2000;19:120–5.
Maalej M, Frikha H, Ben Salem S, Daoud J, Bouaouina N, Ben Abdallah M, et al: [Breast cancer in Tunisia: clinical and epidemiological study]. Bulletin du Cancer. 1999;86:302–6.
El Bolkainy MN: Breast cancer. Cairo: The National Cancer Institute, Cairo University; 2000.
Ijaduola TG, Smith EB: Pattern of breast cancer among white-American, African-American, and nonimmigrant west-African women. Journal of the National Medical Association. 1998;90:547–51.
Omar SH, El Aaser A, Eissa S, al. e: End results of breast cancer therapy. II: Clinical immunological and hormonal profile of inflammatory carcinoma of the breast. A.: Clinicopathological aspects. Cancer Prevention & therapy 1989;1.
Amir H, Kaaya EE, Kwesigabo G, Kiitinya JN: Breast cancer before and during the AIDS epidemic in women and men: a study of Tanzanian Cancer Registry Data 1968 to 1996. Journal of the National Medical Association. 2000;92:301–5.
Amir H, Makwaya C, Mhalu F, Mbonde MP, Schwartz-Albiez R: Breast cancer during the HIV epidemic in an African population. Oncology Reports. 2001;8:659–61.
Fina F, Romain S, Ouafik L, Palmari J, Ben Ayed F, Benharkat S, et al: Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. British Journal of Cancer. 2001;84:783–90.
Ly M, Diop S, Sacko M, Baby M, Diop CT, Diallo DA: [Breast cancer: factors influencing the therapeutic itinerary of patients in a medical oncology unit in Bamako (Mali)]. Bulletin du Cancer. 2002;89:323–6.
Odusanya OO, Tayo OO: Breast cancer knowledge, attitudes and practice among nurses in Lagos, Nigeria. Acta Oncologica. 2001;40:844–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer
About this chapter
Cite this chapter
Khaled, H.M. (2006). Breast Cancer at Diagnosis in Women of Africa and the Middle East. In: Williams, C.K.O., Olopade, O.I., Falkson, C.I. (eds) Breast Cancer in Women of African Descent. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-3664-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4020-3664-4_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-3682-8
Online ISBN: 978-1-4020-3664-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)